ImmunAdd today announced an update on the progress of its patent portfolio. Effective this year, the company has adopted a new disclosure policy under which it no longer announces the grant or filing status of individual patents on a case-by-case basis, and instead provides periodic, consolidated updates on the overall progress of its portfolio. As […]